Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amviacal is a multi-ingredient nutritional supplement developed by Amvia Biotech. It is formulated as an oral tablet containing a combination of calcium citrate (1000 mg), magnesium (100 mg), zinc (4 mg), and vitamin D3 (cholecalciferol, 200 IU). The supplement is primarily indicated for supporting bone health and addressing deficiencies in calcium and magnesium. Calcium citrate provides a highly bioavailable source of calcium for bone mineralization, while vitamin D3 enhances intestinal calcium absorption by acting as an agonist at the vitamin D receptor. Magnesium and zinc serve as essential cofactors in bone metabolism and various enzymatic processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Amviacal.